Accumulating evidence suggests that infections may play a major role in Alzheimer's disease (AD), however, mechanism is unclear, as multiple pathways may be involved. One possibility is that infections could contribute to neurodegeneration directly by promoting neuronal death. We explored relationships between history of infections and brain hippocampal volume (HV), a major biomarker of neurodegeneration, in a subsample of the UK Biobank (UKB) participants. Infectious disease diagnoses were based on ICD10 codes. The left/right HV was measured by the magnetic resonance imaging (MRI) in cubic millimeters and normalized. Analysis of variance (ANOVA), Welch test, and regression were used to examine statistical significance. We found that HV was...
Objective: Amyloid positivity is a biomarker of AD pathology, yet the associations between amyloid p...
Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disorder and according to th...
Alzheimer’s disease (AD) has a long preclinical phase, beginning decades prior to the onset of demen...
Accumulating evidence suggests that infections may play a major role in Alzheimer's disease (AD), ho...
© 2018, © 2018 Taylor & Francis. This study examined biological sex differences in the development...
IntroductionChronic neuroinflammatory events have been implicated in the pathophysiology of neurodeg...
Alzheimer's disease (AD) is a complex disease resulting in neurodegeneration and cognitive impairmen...
INTRODUCTION: Dementia is a major contributor to disability and dependence worldwide and is currentl...
BACKGROUND: Hippocampal volume (HV) atrophy is a well-known biomarker of memory impairment. However,...
Objective To test the hypothesis that genetic risk for Alzheimer disease (AD) may represent a stable...
ObjectiveTo examine sex differences in the relationship between clinical symptoms related to Alzheim...
Female sex, age and carriage of the apolipoprotein E e4 allele are the greatest risk factors for spo...
Background: Common infections have been associated with dementia risk; however, evidence is scarce. ...
Reduced volumes of the hippocampus (HC) and amygdala (AG) are potential biomarkers for Alzheimer's d...
In Australia, it is estimated that 487,500 people live with dementia, with projections that this num...
Objective: Amyloid positivity is a biomarker of AD pathology, yet the associations between amyloid p...
Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disorder and according to th...
Alzheimer’s disease (AD) has a long preclinical phase, beginning decades prior to the onset of demen...
Accumulating evidence suggests that infections may play a major role in Alzheimer's disease (AD), ho...
© 2018, © 2018 Taylor & Francis. This study examined biological sex differences in the development...
IntroductionChronic neuroinflammatory events have been implicated in the pathophysiology of neurodeg...
Alzheimer's disease (AD) is a complex disease resulting in neurodegeneration and cognitive impairmen...
INTRODUCTION: Dementia is a major contributor to disability and dependence worldwide and is currentl...
BACKGROUND: Hippocampal volume (HV) atrophy is a well-known biomarker of memory impairment. However,...
Objective To test the hypothesis that genetic risk for Alzheimer disease (AD) may represent a stable...
ObjectiveTo examine sex differences in the relationship between clinical symptoms related to Alzheim...
Female sex, age and carriage of the apolipoprotein E e4 allele are the greatest risk factors for spo...
Background: Common infections have been associated with dementia risk; however, evidence is scarce. ...
Reduced volumes of the hippocampus (HC) and amygdala (AG) are potential biomarkers for Alzheimer's d...
In Australia, it is estimated that 487,500 people live with dementia, with projections that this num...
Objective: Amyloid positivity is a biomarker of AD pathology, yet the associations between amyloid p...
Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disorder and according to th...
Alzheimer’s disease (AD) has a long preclinical phase, beginning decades prior to the onset of demen...